Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

News
1 - 10of about 318 News
1 - 10of about 318 News
February 08, 2023
Bill Anderson to become CEO of Bayer AG
READ MORE
February 06, 2023
Not intended for U.S. and UK Media
Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU
READ MORE
February 02, 2023
Bayer and Kimitec join forces to bring the next generation of Biologicals to millions of growers worldwide
READ MORE
January 31, 2023
Bayer to distribute pheromone-based biological crop protection solutions from M2i Group
READ MORE
January 27, 2023
Not intended for U.S. and UK Media
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
READ MORE
January 19, 2023
Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
READ MORE
January 10, 2023
Not intended for U.S. and U.K. Media
Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros
READ MORE
December 16, 2022
Not intended for U.S. and UK Media
Finerenone receives positive CHMP opinion for EU-label extension for broad range of patients with chronic kidney disease and type 2 diabetes
READ MORE
December 14, 2022
Bayer recognized as leader on climate change for fifth consecutive year
READ MORE
November 11, 2022
Not intended for U.S. and UK Media
Bayer receives positive CHMP opinion for Eylea™ in the EU for treatment of preterm infants with retinopathy of prematurity
READ MORE
1 - 10of about 318 News
1 - 10of about 318 News

 

Subscribe To Our Investor News Email Alerts

Ad-Hoc Releases
Discover Bayer's Latest Ad-Hoc Releases
read more